Showing results (241-250 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spreadCecilia Hindorf, Dimitris Emfietzoglou, Ola Lindén, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumorsPaul J J M Janssen, Moniaue de Visser, Suzanne M Verwijnen, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Preparation and imaging research on 188Re-DTPA-deoxyglucose in MCF-7 tumor-bearing miceYue Chen, Qingfeng Xiong, Xiqun Yang, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Noninvasive scintigraphic detection of tumor with 99mTc-DTPA-deoxyglucose: an experimental studyYue Chen, Qingfeng Xiong, Xiqun Yang, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOCChristiane Wehrmann, Stefan Senftleben, Carolin Zachert, et al.Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Preparation and quality control of [166Ho]-macroaggregates for radiosynoviorthesisMartin Kropácek, F Melichar, J Srank, et al.Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Radiobiology of systemic radiation therapyDavid Murray, Alexander J McEwanCancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary resultsCarlo Chiesa, Francesca Botta, Erika Di Betta, et al.Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organsCristina Müller, Flavio Forrer, Bert F Bernard, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trialAgustin Avilés, María Jesus Nambo, Claudia Castañeda, et al.Pageof 223